A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity

Autor: Schabowsky, Rich-Henry, Elpek, Kutlu G., Madireddi, Shravan, Sharma, Rajesh K., Yolcu, Esma S., Bandura-Morgan, Laura, Miller, Robert, MacLeod, Kathryn J., Mittler, Robert S., Shirwan, Haval
Zdroj: In Vaccine 2009 28(2):512-522
Databáze: ScienceDirect